Franco-Nevada Corporation · FNV · FY2025 Q1 · Calendar Q2 2025
Franco-Nevada: Growth Pipeline Advances, Panama Risk Remains
Franco-Nevada’s growth case is supported by higher gold prices, new royalty assets and mine ramp-ups, but commodity sensitivity and the unresolved Cobre Panama situation keep the outlook conditional.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about FNV FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The quarter added evidence of operating momentum: management described record Q1 results without Cobre Panama cash flow, highlighted recently completed acquisitions and emphasized production ramp-ups. The company also indicated that further stream-to-NSR conversions are not expected near term, while Panama negotiations remain active.
Guidance delta
Management maintained its outlook; no increase or reduction was supplied.
Key takeaways
- Record Q1 revenue was attributed to higher gold prices and newly acquired assets, despite no Cobre Panama cash flow.
- Management highlighted a debt-free balance sheet, available capital, mine ramp-ups and a pipeline of royalty and streaming opportunities.
- The company said no further stream-to-NSR conversions are expected in the near term while Panama discussions continue.
Management priorities
- Add high-margin royalty assets, with targeted deals of $100–$500 million.
- Accelerate production at Tocantinzinho, Greenstone and Valentine Gold.
- Continue discussions around Cobre Panama while maintaining a balanced GEO profile.
Follow FNV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 18, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Sep 16, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Jul 14, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Jefferies | Hold | Hold | Maintain | Jul 6, 2026 |
| UBS | Buy | Buy | Maintain | Jun 30, 2026 |
| TD Cowen | Buy | Hold | Upgrade | May 20, 2026 |
| HC Wainwright & Co. | Buy | Buy | Maintain | May 13, 2026 |
| TD Securities | Hold | Hold | Maintain | Nov 5, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Oct 10, 2025 |
| Barclays | Underweight | Underweight | Maintain | Jul 7, 2023 |
| Keybanc | Overweight | Overweight | Maintain | Jul 18, 2022 |
| JP Morgan | Neutral | Neutral | Maintain | Mar 4, 2021 |
| Deutsche Bank | Hold | Hold | Maintain | Jun 17, 2020 |
| Credit Suisse | Neutral | Neutral | Maintain | Aug 8, 2019 |
| GMP Securities | Hold | Buy | Downgrade | Jul 23, 2019 |
| Dundee | Buy | Neutral | Upgrade | Dec 8, 2016 |
| Canaccord Genuity | Buy | Hold | Upgrade | Nov 15, 2016 |
| Desjardins | Buy | Buy | Maintain | Oct 26, 2016 |
| National Bank Financial Inc | Sector Perform | Outperform | Downgrade | Oct 13, 2016 |
| National Bank FInancial | Sector Perform | Outperform | Downgrade | Oct 13, 2016 |
| BMO Capital | Market Perform | Outperform | Downgrade | May 12, 2016 |
| Goldman Sachs | Sell | Neutral | Downgrade | May 11, 2016 |
| Clarksons Platou | Buy | Buy | Maintain | Feb 16, 2016 |
| Macquarie | Outperform | Outperform | Maintain | May 14, 2015 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 29, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $243.72. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Scotiabank | Tanya Jakusconek | $274 | $202.32 | +12.4% | Jul 14, 2026 |
| RBC Capital | Analyst unavailable | $285 | $207.5 | +16.9% | Jul 9, 2026 |
| Jefferies | Analyst unavailable | $245 | $217.58 | +0.5% | Jul 6, 2026 |
| UBS | Daniel Major | $280 | $204.5 | +14.9% | Jun 30, 2026 |
| TD Securities | Analyst unavailable | $291 | $222.74 | +19.4% | May 20, 2026 |
| Scotiabank | Analyst unavailable | $290 | $237.11 | +19.0% | May 14, 2026 |
| H.C. Wainwright | Heiko Ihle | $305 | $265.72 | +25.1% | Mar 12, 2026 |
| H.C. Wainwright | Analyst unavailable | $285 | $250.65 | +16.9% | Feb 13, 2026 |
| UBS | Analyst unavailable | $310 | $242.45 | +27.2% | Jan 30, 2026 |
| Scotiabank | Analyst unavailable | $283 | $265.05 | +16.1% | Jan 26, 2026 |
| RBC Capital | Josh Wolfson | $250 | $202.93 | +2.6% | Dec 10, 2025 |
| Jefferies | Analyst unavailable | $228 | $203.17 | -6.5% | Dec 7, 2025 |
| UBS | Analyst unavailable | $270 | $208.1 | +10.8% | Dec 1, 2025 |
| H.C. Wainwright | Analyst unavailable | $210 | $185.14 | -13.8% | Nov 4, 2025 |
| Scotiabank | Tanya Jakusconek | $225 | $191.21 | -7.7% | Oct 23, 2025 |
| UBS | Daniel Major | $260 | $209.43 | +6.7% | Oct 16, 2025 |
| Raymond James | Analyst unavailable | $234 | $203.78 | -4.0% | Oct 10, 2025 |
| Raymond James | Brian MacArthur | $218 | $214.17 | -10.6% | Sep 23, 2025 |
| UBS | Daniel Major | $250 | $208.58 | +2.6% | Sep 19, 2025 |
| Raymond James | Brian MacArthur | $186 | $168.5 | -23.7% | May 28, 2025 |
| Scotiabank | Analyst unavailable | $150 | $145.74 | -38.5% | Mar 11, 2025 |
| TD Securities | Derick Ma | $152 | $145.74 | -37.6% | Mar 11, 2025 |
| Bank of America Securities | Lawson Winder | $139 | $124.46 | -43.0% | Oct 1, 2024 |
| Scotiabank | Tanya Jakusconek | $141 | $122.71 | -42.1% | May 23, 2024 |
| H.C. Wainwright | Analyst unavailable | $145 | $133.79 | -40.5% | Aug 11, 2022 |
| H.C. Wainwright | Analyst unavailable | $144 | $126 | -40.9% | Jul 19, 2022 |
| H.C. Wainwright | Analyst unavailable | $180 | $156.09 | -26.1% | May 5, 2022 |
| Industrial Alliance Securities | Puneet Singh | $187 | $130.35 | -23.3% | Jan 21, 2022 |
| KeyBanc | Adam Josephson | $154.38 | $134.33 | -36.7% | Dec 22, 2021 |
| Desjardins | John Sclodnick | $159.15 | $150.21 | -34.7% | May 20, 2021 |
Track every rating change on FNV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationFranco-Nevada Corporation operates as a royalty and stream company focused on precious metals in South America, Central America, Mexico, the United States, Canada, Australia, Europe, and Africa. It operates through Precious Metals, Other Mining and Energy segments. The company manages its portfolio with a focus on precious metals, such as gold, silver, and platinum group metals; and engages in the sale of crude oil, natural gas, and natural gas liquids through a third-party marketing agent. The company was founded in 1986 and is headquartered in Toronto, Canada.
Historical context
All FNV earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| AA Alcoa Corporation | FY2026 Q3 · Calendar Q4 2026 | +20.5% | +7.2% | Alcoa: Strong Q3 execution, with safety and transaction risks ahead |
Latest beats and misses
Who reports nextBeat on EPS
Get the FNV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-24T00:01:17.206701+00:00
- Polygon adjusted daily market bars · 2026-10-18T02:20:43.924193+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-18T02:20:43.921366+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-18. For educational purposes only; not investment advice.